ImmuCell Corporation Deferred Federal, State and Local, Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Deferred Federal, State and Local, Tax Expense (Benefit) of -$332.65 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2026-03-30
- ImmuCell Corporation deferred federal, state and local, tax expense (benefit) for fiscal 2025 was -$332.65K.
- ImmuCell Corporation deferred federal, state and local, tax expense (benefit) for fiscal 2024 was -$559.96K, a 142.25% decline from fiscal 2023.
- ImmuCell Corporation deferred federal, state and local, tax expense (benefit) for fiscal 2023 was $1.33M, a 99.20% increase from fiscal 2022.
- ImmuCell Corporation deferred federal, state and local, tax expense (benefit) for fiscal 2022 was $665.31K.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$332.65K 10-K · filed 2026-03-30 | |
| 2024-12-31 | -$559.96K 10-K · filed 2026-03-30 | $559.96K 10-K · filed 2025-03-28 |
| 2023-12-31 | $1.33M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $665.31K 10-K · filed 2024-04-01 | |
| 2020-12-31 | -$442.63K 10-K · filed 2021-03-30 | |
| 2019-12-31 | -$271.66K 10-K · filed 2021-03-30 | |
| 2018-12-31 | -$778.57K 10-K · filed 2020-03-27 | |
| 2017-12-31 | -$284.81K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |